{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-084699","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.861048+00:00","generated_at":"2026-06-17T08:53:56.967900+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Agenus declares dividend of 5M shares of MiNK Therapeutics to shareholders","bullets":["Record date April 17, 2023; payment no earlier than April 27 and no later than May 17, 2023.","Pro rata distribution; no fractional shares; cash in lieu based on MiNK closing price on record date.","CEO Garo Armen says dividend demonstrates commitment to delivering additional shareholder value.","MiNK to present updated clinical data for agenT-797 at AACR Annual Meeting April 14-19, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-084699","json":"https://secwatch.observer/filing/0001193125-23-084699.json","markdown":"https://secwatch.observer/filing/0001193125-23-084699.md","text":"https://secwatch.observer/filing/0001193125-23-084699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000119312523084699/0001193125-23-084699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000119312523084699/d480291d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:53:56.967900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}